Abstract
The efficacy of 6-O-QS-10-N-acetyl muramyl-L-valyl-D-isoglutamine methyl ester (quinonyl-MDP-66) for restoring impaired immune status was examined in mice bearing Lewis lung carcinoma. Quinonyl-MDP-66 suspended in phosphate-buffered saline was shown to restore the depressed allogeneic cell-mediated cytotoxicity of spleen cells from mice with Lewis lung carcinoma when the chemical was injected twice intraperitoneally, intravenously, or intratumorally. However, primary tumor size and the numbers of lung metastases were not affected when quinonyl-MDP-66 was administered under the present experimental conditions. Intraperitoneal injection of quinonyl-MDP-66 in mice with Lewis lung carcinoma enhanced host resistance to Listeria monocytogenes infection.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adam A., Ciorbaru R., Ellouz F., Petit J. F., Lederer E. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun. 1974 Feb 4;56(3):561–567. doi: 10.1016/0006-291x(74)90640-8. [DOI] [PubMed] [Google Scholar]
- Adam A., Devys M., Souvannavong V., Lefrancier P., Choay J., Lederer E. Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun. 1976 Sep 7;72(1):339–346. doi: 10.1016/0006-291x(76)90999-2. [DOI] [PubMed] [Google Scholar]
- Anaclerio A., Moras M. L., Conti G., Mistrello G., Spreafico F. Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma. J Natl Cancer Inst. 1978 Aug;61(2):471–475. [PubMed] [Google Scholar]
- Anderson S. A., Isakson P. C., Puré E., Muirhead M., Uhr J. W., Vitetta E. S. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses. J Immunol. 1981 Apr;126(4):1603–1607. [PubMed] [Google Scholar]
- Azuma I., Yamawaki M., Uemiya M., Saiki I., Tanio Y., Kobayashi S., Fukuda T., Imada I., Yamamura Y. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides. Gan. 1979 Dec;70(6):847–848. [PubMed] [Google Scholar]
- Brunner K. T., Mauel J., Rudolf H., Chapuis B. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology. 1970 Apr;18(4):501–515. [PMC free article] [PubMed] [Google Scholar]
- Carnaud C., Hoch B., Trainin N. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice. J Natl Cancer Inst. 1974 Feb;52(2):395–399. doi: 10.1093/jnci/52.2.395. [DOI] [PubMed] [Google Scholar]
- Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
- Fidler I. J., Sone S., Fogler W. E., Barnes Z. L. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1680–1684. doi: 10.1073/pnas.78.3.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fidler I. J. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science. 1980 Jun 27;208(4451):1469–1471. doi: 10.1126/science.7384789. [DOI] [PubMed] [Google Scholar]
- Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
- Fujimoto S., Greene M. I., Sehon A. H. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):800–806. [PubMed] [Google Scholar]
- Haller O., Hansson M., Kiessling R., Wigzell H. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature. 1977 Dec 15;270(5638):609–611. doi: 10.1038/270609a0. [DOI] [PubMed] [Google Scholar]
- Hanna N., Fidler I. J. Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst. 1980 Oct;65(4):801–809. doi: 10.1093/jnci/65.4.801. [DOI] [PubMed] [Google Scholar]
- Hanna N. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res. 1982 Apr;42(4):1337–1342. [PubMed] [Google Scholar]
- Kamo I., Friedman H. Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res. 1977;25:271–321. doi: 10.1016/s0065-230x(08)60636-3. [DOI] [PubMed] [Google Scholar]
- Kobayashi S., Fukuda T., Imada I., Fujino M., Azuma I., Yamamura Y. Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity. Chem Pharm Bull (Tokyo) 1979 Dec;27(12):3193–3196. doi: 10.1248/cpb.27.3193. [DOI] [PubMed] [Google Scholar]
- Kotani S., Watanabe Y., Kinoshita F., Shimono T., Morisaki I. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 1975 Jun;18(2):105–111. [PubMed] [Google Scholar]
- Mantovani A., Giavazzi R., Polentarutti N., Spreafico F., Garattini S. Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int J Cancer. 1980 May 15;25(5):617–620. doi: 10.1002/ijc.2910250511. [DOI] [PubMed] [Google Scholar]
- Matsuo K., Nomoto K., Shimotori S., Takeya K. Depression of protective mechanisms against microörganisms in tumor-bearing mice and its restoration by adjuvants. Gan. 1977 Aug;68(4):465–471. [PubMed] [Google Scholar]
- Miyata H., Himeno K., Miake S., Nomoto K. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum. Immunology. 1981 Oct;44(2):305–310. [PMC free article] [PubMed] [Google Scholar]
- Saiki I., Tanio Y., Yamawaki M., Uemiya M., Kobayashi S., Fukuda T., Yukimasa H., Yamamura Y., Azuma I. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs. Infect Immun. 1981 Jan;31(1):114–121. doi: 10.1128/iai.31.1.114-121.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sone S., Fidler I. J. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol. 1981 Jan 1;57(1):42–50. doi: 10.1016/0008-8749(81)90118-0. [DOI] [PubMed] [Google Scholar]
- Talmadge J. E., Meyers K. M., Prieur D. J., Starkey J. R. Role of NK cells in tumour growth and metastasis in beige mice. Nature. 1980 Apr 17;284(5757):622–624. doi: 10.1038/284622a0. [DOI] [PubMed] [Google Scholar]
- Treves A. J., Carnaud C., Trainin N., Feldman M., Cohen I. R. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol. 1974 Nov;4(11):722–727. doi: 10.1002/eji.1830041104. [DOI] [PubMed] [Google Scholar]
- Umiel T., Trainin N. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes. Transplantation. 1974 Sep;18(3):244–250. doi: 10.1097/00007890-197409000-00007. [DOI] [PubMed] [Google Scholar]
- Vaage J., Chen K., Merrick S. Effect of immune status on the development of artificially induced metastases in different anatomical locations. Cancer Res. 1971 May;31(5):496–500. [PubMed] [Google Scholar]
- Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst. 1966 Apr;36(4):641–645. doi: 10.1093/jnci/36.4.641. [DOI] [PubMed] [Google Scholar]